Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( January )
Working Life: Les Hughes
AstraZeneca's global vice president, cancer and infection research on working his way up from a bench scientist(more)
The Pharmafocus Interview: Elmar Schnee
Merck's head of pharmaceuticals on the advantages of a diverse business model and the maddening 'disaster' that is Germany's cost effectiveness body IQWIG(more)
2008: A year in the life of UK pharma
Patient power, pharma streamlining and the rest of the stories that shaped the industry over the last 12 months(more)
PharmafocusNews Register for New Alert
News for October 2008
Previous Months: December 2008 |  November 2008 |  October 2008 |  September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Strong results for Novartis drug in rare autoimmune disease
Canakinumab performs in Cryopyrin-Associated Periodic Syndromes..(more)

 Contraceptive and Betaferon sales bolster Bayer
But total pharma sales only manage a small single-digit rise..(more)

 Call for more not-for-profit healthcare providers
NHS Alliance says social enterprise model is the way forward..(more)

 Study boost for Roche's Actemra
Data shows drug increases disease remission rate in RA..(more)

 Bayer's 'revolutionary' anticoagulant Xarelto launched
NICE appraisal of the drug already begun..(more)

 Latest news from Datamonitor
Sales of targeted cancer drugs to top $42 billion by 2017..(more)

 Roche dips on Tamiflu decline
Oncolgy portfolio shines, but Tamiflu drags results down..(more)

 Merck to streamline management structure
Company restructures and cuts jobs to update business model..(more)

 Novartis appoints Reinhardt as chief operating officer
Move seen as succession plan for chairman and chief executive Daniel Vasella..(more)

 PPRS talks stall
Government to hold public consultation about off-patent medicines..(more)

 Leaders use war gaming to strengthen UK biotech
Aim to show companies how to emulate their US counterparts..(more)

 Latest news from Datamonitor
Opportunity knocks for big pharma in the credit crunch..(more)

 Companies try to quell rumours on prasugrel
Daiichi-Sankyo and Lilly respond to media speculation..(more)

 MedImmune opens new R&D facility in Cambridge
Granta Park site will house up to 250 employees..(more)

 NHS improving but London lags behind
Healthcare Commission releases third snapshot of NHS in England..(more)

 Bayer Schering Pharma's Qlaira approved in Europe
First-in-class contraceptive expected to be launched next year..(more)

 Pfizer repackages range for safety
Dosing instructions will be made clearer..(more)

 GSK takes Egyptian lead
Product acquisitions part of company's emerging markets expansion plans..(more)

 Wyeth pulls European application for Ellefore
But company committed to bringing Efexor successor to market..(more)

 Government looks to plug health research gaps
Health Services Research programme designed to fund non-mainstream research..(more)

 GSK's pricing deal for Tyverb fails to sway NICE
Institute's draft guidance does not recommend drug, despite risk-sharing proposal..(more)

 Patient advocates fear 'nightmare' effects of top-up payments
Allowing co-payments could make things worse for patients..(more)

 Johnson & Johnson appoints new global pharma chair
Sheri McCoy to succeed Christine Poon in January..(more)

 Pharma prepares for battle over EU patient information
But reiterates opposition to direct-to-consumer advertising..(more)

 Oxford BioMedica fills leadership vacancy
Acting leader John Dawson steps up to permanent role..(more)

 Latest news from Datamonitor
Battle for HIV drug market share getting fiercer..(more)

 England's mental health policy leading Europe, says WHO
Last 10 years have seen a transformation..(more)

 Novartis pursues pulmonary hypertension indication for Glivec
Drug's potential in pulmonary arterial hypertension will be further explored next year..(more)

 Lilly eyes oncology focus with ImClone acquisition
Trumps Bristol-Myers Squibb bid with $6.5 billion offer..(more)

 GlycArt's new cancer candidate to be developed with Roche
GA101 already in phase I/II clinical trials for CD20-positive B-cell malignancies..(more)

 UK is example to Europe on patient information, says industry
Liberal environment allows close pharma-stakeholder relations..(more)

 Advertising start-up is UK's 'first virtual healthcare agency'
Internet-based service will offer greener, flexible, cost-effective advertising..(more)

 Latest news from Datamonitor
Does Rx-to-OTC protect revenues and cut healthcare costs? ..(more)

 Norgine quits ABPI and denounces big pharma bias
Company blames PPRS pricing negotiations for exit..(more)

 GSK plans research job losses in UK
Worldwide around 850 positions set to be cut..(more)

 Spiriva partners defend drug's safety
Boehringer Ingelheim and Pfizer release new data on the COPD treatment..(more)

 Osteoporosis drug Aclasta approved for use in men
Novartis treatment extends its European licence..(more)

 Long-acting Zyprexa gets green light
EC advisors recommend Lilly's schizophrenia drug..(more)

 MHRA unveils medicine information resource
Regulator partners with ABPI on drug lifecycle website..(more)

 Credit crunch hits European biotech
Small and medium-sized companies being starved of funding..(more)

 Weak currency helps UK pharmaceutical industry
Competition from European parallel imports falls..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2009 Wiley Pharmafile Ltd.